Centre | Country/continent | Total number of families | Total number of patients with CMM | Number of families with CDKN2A mutations | References for family ascertainment |
---|---|---|---|---|---|
CMM, cutaneous malignant melanoma. | |||||
Boston | USA/North America | 3 | 9 | 0 | 18 |
Leeds | USA/North America | 1 | 3 | 0 | 29 |
NCI | USA/North America | 38 | 192 | 19 | 19, 20 |
Philadelphia | USA/North America | 5 | 18 | 1 | |
Utah | USA/North America | 11 | 150 | 5 | 21 |
Toronto | Canada/North America | 7 | 22 | 4 | |
North America | 65 | 394 | 29 | ||
Barcelona | Spain/Europe | 11 | 38 | 5 | 22– 25 |
Emilia-Romagna | Italy/Europe | 8 | 27 | 1 | 26 |
Genoa | Italy/Europe | 8 | 31 | 5 | 11 |
Glasgow | Scotland/Europe | 10 | 31 | 6 | 9, 27 |
Leeds | England/Europe | 29 | 107 | 22 | 28– 30 |
Leiden | The Netherlands/Europe | 26 | 154 | 19 | 31, 32 |
Paris | France/Europe | 40 | 133 | 19 | 6, 33, 34 |
Lund | Sweden/Europe | 15 | 60 | 8 | 12, 35 |
Stockholm | Sweden/Europe | 10 | 36 | 4 | 36– 38 |
Europe | 157 | 617 | 89 | ||
Brisbane | Australia | 100 | 446 | 18 | 39– 42 |
Sydney | Australia | 62 | 258 | 14 | 10, 28, 43, 44 |
Australia | 162 | 704 | 32 | ||
Tel-Aviv | Israel/Asia | 1 | 5 | 0 | |
Total | 385 | 1720 | 150 |